Investor's Business Daily on MSN23h
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Moderna beat Wall Street's first-quarter expectations Thursday. The news could bolster Moderna stock, which is approaching ...
Yahoo6d
FDA approves Pfizer's first gene therapy for rare inherited bleeding disorder
The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S. The ...
Seeking Alpha6d
Pfizer gets FDA approval for hemophilia B gene therapy Beqvez
Pfizer (NYSE:PFE) said it has received FDA approval for its one-time gene therapy Beqvez for the treatment of certain adults with hemophilia B. The drugmaker said the therapy is aimed at enabling ...
Yahoo Finance6d
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Friday, the FDA approved Pfizer Inc’s (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate to severe hemophilia B in adult patients who currently use factor IX (FIX) prophylaxis ...
Pharm Exec6d
FDA Approves Pfizer’s Beqvez for the Treatment of Adults with Moderate to Severe Hemophilia B
Pfizer announced that the FDA has approved Beqvez (fidanacogene elaparvovec-dzkt) as a one-time gene therapy for adults with moderate to severe hemophilia B. The therapy is indicated for patients who ...
Reuters6d
US FDA approves Pfizer's gene therapy for rare bleeding disorder
It predominately affects males. Pfizer's one-time therapy, branded as Beqvez, is designed to stimulate production of the protein, called factor IX (FIX), by the patient's own body instead of ...
Seeking Alpha6d
Pfizer gets FDA approve for hemophilia B gene therapy
Pfizer (NYSE:PFE) said it has received FDA approval for its one-time gene therapy Beqvez for the treatment of certain adults with hemophilia B. The drugmaker said the therapy is aimed at enabling ...
Investing6d
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Benzinga - by Vandana Singh, Benzinga Editor. Friday, the FDA approved Pfizer Inc’s (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate to severe hemophilia B in adult patients who ...
FiercePharma2d
Regulatory tracker: FDA offers Pfizer's Tivdak full nod in cervical cancer
The FDA approved the subcutaneous form as a maintenance ... versus just 11% in the placebo group, at the 12-week mark. Pfizer-BioNTech’s and Moderna’s mRNA-based COVID-19 vaccines have been ...
MercoPress4d
COVID-19 booster shots are better if specific brands are used
The findings reinforce advice recommending that those who received the J&J vaccine receive a second booster dose with an mRNA vaccine, the technology used in the Moderna and Pfizer shots ...
pharmaphorum4d
FDA clears Pfizer's Prevnar 20 for adults, as Merck rival nears decision
Pfizer has the FDA approval it was seeking for Prevnar 20 ... The studies included a booster shot with Merck's older polysaccharide-based Pneumovax 23 vaccine, which is still widely used in ...